How should the <213> numeric identifier be used in a sequence listing?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30

This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.

The numeric identifier in a sequence listing has a specific use according to the Manual of Patent Examining Procedure (MPEP). As stated in MPEP 2424.02:

“ is used for the name of the organism from which the sequence was obtained”

This means that when providing a sequence listing, you should use the identifier to specify the organism from which the genetic sequence was derived. This information is crucial for understanding the biological context of the sequence and its potential applications or implications in biotechnology patents.

For example, if you’re listing a sequence obtained from Escherichia coli, you would use the identifier followed by “Escherichia coli” in your sequence listing.

Topics: MPEP 2400 - Biotechnology MPEP 2424.02 - "Sequence Listing" Numeric Identifiers Patent Law Patent Procedure
Tags: Sequence Format